🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/02/1987 | 7,98 | 8,00 | 7,90 | 7,93 | +1,18% | 1,33% | 22.070.880 |
| 19/02/1987 | 7,52 | 7,85 | 7,47 | 7,83 | +4,51% | 4,93% | 15.072.336 |
| 18/02/1987 | 7,82 | 7,85 | 7,42 | 7,49 | -1,82% | 5,42% | 16.047.605 |
| 17/02/1987 | 7,40 | 7,67 | 7,40 | 7,63 | +3,23% | 3,76% | 8.915.126 |
| 13/02/1987 | 7,25 | 7,45 | 7,25 | 7,40 | +2,48% | 2,74% | 8.624.621 |
| 12/02/1987 | 7,12 | 7,26 | 7,11 | 7,22 | +1,87% | 2,14% | 11.899.411 |
| 11/02/1987 | 7,16 | 7,16 | 7,05 | 7,08 | -0,74% | 1,48% | 10.601.568 |
| 10/02/1987 | 7,23 | 7,25 | 7,10 | 7,14 | -1,19% | 2,02% | 7.796.491 |
| 09/02/1987 | 7,20 | 7,26 | 7,16 | 7,22 | -0,27% | 1,47% | 6.259.075 |
| 06/02/1987 | 7,25 | 7,29 | 7,20 | 7,24 | -0,27% | 1,28% | 5.581.858 |
| 05/02/1987 | 7,32 | 7,34 | 7,18 | 7,26 | -0,55% | 2,17% | 8.349.206 |
| 04/02/1987 | 7,36 | 7,36 | 7,26 | 7,30 | -0,36% | 1,26% | 7.223.026 |
| 03/02/1987 | 7,38 | 7,40 | 7,26 | 7,33 | -0,54% | 1,89% | 7.792.718 |
| 02/02/1987 | 7,28 | 7,46 | 7,24 | 7,37 | +1,09% | 3,10% | 7.107.955 |
| 30/01/1987 | 7,22 | 7,30 | 7,17 | 7,29 | +0,92% | 1,84% | 6.366.600 |
| 29/01/1987 | 7,45 | 7,46 | 7,18 | 7,22 | -2,50% | 3,74% | 8.283.182 |
| 28/01/1987 | 7,42 | 7,45 | 7,26 | 7,41 | +2,10% | 2,50% | 10.860.005 |
| 27/01/1987 | 7,21 | 7,32 | 7,16 | 7,26 | +2,15% | 2,21% | 10.537.430 |
| 26/01/1987 | 7,13 | 7,15 | 7,01 | 7,10 | -0,19% | 1,95% | 9.958.306 |
| 23/01/1987 | 7,34 | 7,66 | 7,08 | 7,12 | -1,83% | 7,94% | 19.618.560 |
| 22/01/1987 | 7,09 | 7,25 | 7,07 | 7,25 | +2,34% | 2,52% | 10.627.978 |
| 21/01/1987 | 7,02 | 7,14 | 7,02 | 7,08 | +0,47% | 1,70% | 10.145.059 |
| 20/01/1987 | 7,22 | 7,26 | 7,04 | 7,05 | -2,39% | 3,12% | 12.599.266 |
| 19/01/1987 | 7,18 | 7,23 | 7,05 | 7,22 | +0,18% | 2,49% | 8.798.170 |
| 16/01/1987 | 7,09 | 7,21 | 7,05 | 7,21 | +2,35% | 2,24% | 22.070.880 |
| 15/01/1987 | 6,81 | 7,04 | 6,77 | 7,04 | +4,11% | 4,09% | 15.079.882 |
| 14/01/1987 | 6,72 | 6,78 | 6,69 | 6,77 | +0,89% | 1,38% | 9.830.030 |
| 13/01/1987 | 6,73 | 6,76 | 6,71 | 6,71 | -0,69% | 0,79% | 7.023.067 |
| 12/01/1987 | 6,81 | 6,84 | 6,73 | 6,75 | -1,26% | 1,56% | 10.718.525 |
| 09/01/1987 | 6,85 | 6,88 | 6,83 | 6,84 | -0,48% | 0,77% | 8.528.414 |